Prognostic value of fibroblast activation protein expressing tumor volume calculated from [68 Ga]Ga-FAPI PET/CT in patients with esophageal squamous cell carcinoma

被引:0
作者
Liang Zhao
Yizhen Pang
Shanyu Chen
Jianhao Chen
Yimin Li
Yifeng Yu
Chunbin Huang
Long Sun
Hua Wu
Haojun Chen
Qin Lin
机构
[1] Xiamen University,Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine
[2] Xiamen University,Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine
[3] Xinji Health Center,Department of General Surgery
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词
Esophageal squamous cell carcinoma; Fibroblast activation protein inhibitor; PET/CT; Prognosis; Gross tumor volume;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:593 / 601
页数:8
相关论文
共 211 条
[1]  
Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J Clin 71 209-249
[2]  
Ferlay J(2018)Epidemiology of esophageal squamous cell carcinoma Gastroenterology 154 360-373
[3]  
Siegel RL(2021)Intrathoracic vs cervical anastomosis after totally or hybrid minimally invasive esophagectomy for esophageal cancer: a randomized clinical trial JAMA Surg 156 601-610
[4]  
Laversanne M(2014)Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer J Clin Oncol 32 3400-3405
[5]  
Soerjomataram I(1999)Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group JAMA 281 1623-1627
[6]  
Jemal A(2013)Personalizing oncology: perspectives and prospects J Clin Oncol 31 1904-1911
[7]  
Abnet CC(2016)Worldwide Esophageal Cancer Collaboration: clinical staging data Dis Esophagus 29 707-714
[8]  
Arnold M(2018)Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8(th) edition of the TNM staging system for esophageal cancer? J Thorac Dis 10 5192-5198
[9]  
Wei WQ(2020)Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy Acta Radiol 61 1316-1325
[10]  
van Workum F(2020)Textural features based enhanced contrast CT images predicts prognosis to concurrent chemoradiotherapy in stage III esophageal squamous cell cancer Cancer Biomark 27 325-333